Description

4-Quinolone-3-Carboxamide Furan Cb2 Agonist is a high-purity synthetic organic compound designed for advanced research and development. This specialized molecule is of significant interest as a potent and selective agonist for the cannabinoid receptor type 2 (CB2), a key target in modulating inflammatory and immune responses. It is primarily utilized by pharmaceutical R&D teams, academic researchers, and biotechnology companies focused on developing novel therapeutics for pain management, neuroinflammation, and autoimmune disorders.

Application

• Pharmaceutical Research & Development: Serves as a critical reference standard and active lead compound in the discovery of new CB2 receptor-targeting drugs.
• Preclinical Studies: Used in in vitro and in vivo models to investigate CB2 receptor pharmacology, signal transduction pathways, and therapeutic efficacy.
• Neuropharmacology: A key tool for studying the role of the CB2 receptor in neuropathic pain, neurodegenerative diseases (e.g., Alzheimer's, Parkinson's), and neuroinflammation.
• Immunology Research: Employed to explore CB2-mediated modulation of immune cell function and its potential in treating autoimmune conditions like rheumatoid arthritis and multiple sclerosis.
• Biochemical Assay Development: Used as a high-affinity ligand in binding assays (e.g., radioligand displacement) and functional assays (e.g., cAMP, β-arrestin recruitment) to screen and characterize new compounds.
• Chemical Biology: Acts as a molecular probe to elucidate the structure-activity relationships (SAR) of quinolone-carboxamide derivatives interacting with the CB2 receptor.

Basic Information

Product Name	4-Quinolone-3-Carboxamide Furan Cb2 Agonist
CAS No.	1314230-75-5
Molecular Formula	Contact for details
Molecular Weight	Contact for details
Synonyms	CB2 Receptor Agonist (Quinolone series); Furan-2-yl(4-oxo-1,4-dihydroquinoline-3-carbonyl)amide derivative; Selective CB2 agonist; Cannabinoid receptor type 2 agonist; Quinolone-3-carboxamide CB2 ligand; Research compound 1314230-75-5; Potential analgesic/anti-inflammatory agent
EINECS	Contact for details

Quality Control

Every batch of our 4-Quinolone-3-Carboxamide Furan Cb2 Agonist is synthesized and purified under controlled conditions to ensure exceptional consistency and purity suitable for sensitive research applications. Our quality assurance protocol includes comprehensive analytical characterization. Certificates of Analysis (COA) detailing purity, identity, and impurity profiles are provided with each shipment to support your regulatory and research documentation needs.

Storage

Preserve in a tightly closed container, protected from light. Store at controlled room temperature (15-25°C) in a dry environment. For long-term storage, consider storing under an inert atmosphere at -20°C to maximize stability.

Specification

Item	Specification
Appearance	White to off-white solid
Identification (HPLC/MS)	Conforms to structure
Purity (HPLC)	≥ 98.0%
Water Content (KF)	≤ 0.5%
Residue on Ignition	≤ 0.1%
Single Impurity (HPLC)	≤ 0.5%

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.